(Q37965721)

26 August 2017

title

Fluzone(®) Intradermal vaccine: a promising new chance to increase the acceptability of influenza vaccination in adults (English)

1 reference

26 August 2017

1

Filippo Ansaldi

1 reference

26 August 2017

4

Giancarlo Icardi

1 reference

26 August 2017

3

Paolo Durando

1 reference

26 August 2017

Daniela de Florentiis

series ordinal

2

object named as

Daniela de Florentiis

1 reference

26 August 2017

publication date

1 January 2012

1 reference

Expert Review of Vaccines

26 August 2017

published in

1 reference

26 August 2017

volume

11

1 reference

26 August 2017

issue

1

1 reference

26 August 2017

page(s)

17-25

1 reference

Mortality associated with influenza and respiratory syncytial virus in the United States

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.154

Influenza control in the 21st century: Optimizing protection of older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.154

Adult hospitalizations for laboratory-positive influenza during the 2005-2006 through 2007-2008 seasons in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.154

Influenza-associated hospitalizations in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.154

Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.154

The socio-economic burden of influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.154

The annual impact of seasonal influenza in the US: Measuring disease burden and costs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.154

Practice-proven interventions to increase vaccination rates and broaden the immunization season

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.154

Influenza vaccination of health care workers in hospitals--a review of studies on attitudes and predictors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.154

Immunization updates and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.154

Randomized, double-blind comparative trial of subunit and virosomal influenza vaccines for immunocompromised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.154

Human and murine dermis contain dendritic cells. Isolation by means of a novel method and phenotypical and functional characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.154

The cutaneous citadel: a holistic view of skin and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.154

Low-dose intradermal and intramuscular vaccination against hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.154

Clinical evaluation of low-dose intradermally administered hepatitis B virus vaccine. A cost reduction strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.154

Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.154

Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.154

Measles vaccination by the intradermal route

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.154

Different immune responses after intradermal and intramuscular administration of vaccine against tick-borne encephalitis virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.154

Intradermally administered yellow fever vaccine at reduced dose induces a protective immune response: a randomized controlled non-inferiority trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.154

Global production of seasonal and pandemic (H1N1) influenza vaccines in 2009-2010 and comparison with previous estimates and global action plan targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.154

Pandemic influenza vaccines: meeting the supply, distribution and deployment challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.154

Intradermal vaccine delivery: will new delivery systems transform vaccine administration?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.154

Seasonal influenza vaccine delivered by intradermal microinjection: A randomised controlled safety and immunogenicity trial in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.154

Intradermal influenza vaccination of healthy adults using a new microinjection system: a 3-year randomised controlled safety and immunogenicity trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.154

Immunogenicity, large scale safety and lot consistency of an intradermal influenza vaccine in adults aged 18-60 years: Randomized, controlled, phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.154

Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.154

Intradermal influenza vaccine for older adults: a randomized controlled multicenter phase III study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.154

Evaluation of non-inferiority of intradermal versus adjuvanted seasonal influenza vaccine using two serological techniques: a randomised comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.154

Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.154

Perception and acceptance of intradermal influenza vaccination: Patient reported outcomes from phase 3 clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.154

Health care workers: vectors of influenza virus? Low vaccination rate among hospital health care workers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.154

21 January 2018

Identifiers

DOI

10.1586/ERV.11.154

1 reference

26 August 2017

1 reference